Bush Keeps Klausner As NCI Director; Senate Confirms Thompson For HHS.
Golde To Step Down As Physician-in-Chief At Memorial Sloan-Kettering Next Year.
Golde To Step Down At MSK; Porter Joins Hogan & Hartson.
FASEB Calls For 15% Increase For NIH Next Fiscal Year.
Holden Center At U. Of Iowa Designated Comprehensive.
Obit: George Santos, Hopkins Cancer Treatment Pioneer.
Course On Human Research Protections Goes Online @ Cancer.Gov.
FDA Approves Femara As First-Line Treatment For Advanced Breast Cancer.
NCCN Updates Treatment Guidelines To Include CEF For Early Breast Cancer.
US Oncology To Participate In Firm’s Ovarian Cancer Trial.
Atrix, Sanofi In Marketing Deal For Leuprogel Products.
Trending Stories
- U.S. News & World Report expands evaluation of outcomes in cancer subspecialties
- Right-wing provocateur Laura Loomer comes for FDA’s Vinay Prasad
- GOP-led Congress rejects Trump’s plans to gut medical research
Senate bill gives NIH a $400 million raise - Vinay Prasad falls from grace at FDA upon flunking Trump political purity test
MAHA leaders agree on one point: COVID was mishandled. Is that enough to run science-based agencies? - FY25 paylines drop to 4th percentile—a historic low—as NCI braces for Trump’s FY26 budget cuts
- Cancer Research Institute announces 2025 recipients of cancer immunotherapy awards
